Literature DB >> 32001151

Alcohol associated liver disease 2020: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF).

Giovanni Addolorato1, Ludovico Abenavoli2, Marcello Dallio3, Alessandro Federico3, Giacomo Germani4, Stefano Gitto5, Gioacchino Leandro6, Carmelina Loguercio3, Fabio Marra7, Elisa Stasi6.   

Abstract

Alcohol use disorder which includes alcohol abuse and dependence represents one of the leading risk factors for premature mortality in Europe and it is responsible of over 200 conditions, including neuropsychiatric disorders, chronic diseases, cancers and accidents leading to permanent disability. Alcohol use disorder represents the most common cause of liver damage in the Western world, with a wide spectrum of diseases ranging from steatosis, steatohepatitis, fibrosis, cirrhosis and cancer. The present clinical practice guidelines by the Italian Association for the Study of the Liver (AISF) are focused on the current knowledge about epidemiology, pathophysiology, clinical features, diagnosis and treatment of alcohol associated liver disease, aiming to provide practical recommendations on the management of this complex pathological condition.
Copyright © 2019 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alcohol abstinence; Alcohol associated liver disease; Alcohol use disorder; Alcoholic hepatitis; Binge drinking; Liver damage; Liver transplantation; Psychosocial interventions; Treatment

Mesh:

Year:  2020        PMID: 32001151     DOI: 10.1016/j.dld.2019.12.008

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  5 in total

1.  Ways to Prevent the Risk for Cancer and Catch Cancer Early.

Authors:  Farahnak Assadi
Journal:  Int J Prev Med       Date:  2020-11-09

2.  Alcohol use disorder in the COVID-19 era: Position paper of the Italian Society on Alcohol (SIA).

Authors:  Gianni Testino; Teo Vignoli; Valentino Patussi; Pierluigi Allosio; Maria Francesca Amendola; Sarino Aricò; Aniello Baselice; Patrizia Balbinot; Vito Campanile; Tiziana Fanucchi; Livia Macciò; Cristina Meneguzzi; Davide Mioni; Michele Parisi; Doda Renzetti; Raffaella Rossin; Claudia Gandin; Luigi Carlo Bottaro; Giacomo Caio; Lisa Lungaro; Giorgio Zoli; Emanuele Scafato; Fabio Caputo
Journal:  Addict Biol       Date:  2021-09-16       Impact factor: 4.093

Review 3.  Dietary Polyphenols and Non-Alcoholic Fatty Liver Disease.

Authors:  Ludovico Abenavoli; Tiziana Larussa; Alessandro Corea; Anna Caterina Procopio; Luigi Boccuto; Marcello Dallio; Alessandro Federico; Francesco Luzza
Journal:  Nutrients       Date:  2021-02-03       Impact factor: 5.717

4.  Examining the association between opium use, cigarette smoking and alcohol consumption with the liver enzyme levels in a population-based study: Fasa Persian cohort data.

Authors:  Mostafa Bijani; Azizallah Dehghan; Saeed Razavi; Shahnaz Karimi
Journal:  BMC Res Notes       Date:  2022-01-05

Review 5.  Management of Alcohol-Related Liver Disease and Its Complications.

Authors:  Joaquín Cabezas
Journal:  Clin Drug Investig       Date:  2022-04-25       Impact factor: 3.580

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.